Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 1
1948 4
1949 1
1950 2
1951 1
1954 1
1955 2
1956 2
1957 1
1960 2
1961 3
1962 3
1963 2
1964 2
1965 3
1967 1
1968 1
1969 2
1970 3
1971 1
1973 1
1978 1
1982 1
1984 2
1986 4
1987 5
1988 2
1989 3
1999 1
2000 1
2001 1
2003 1
2004 1
2005 3
2006 2
2007 3
2008 7
2009 10
2010 5
2011 2
2012 11
2013 15
2014 12
2015 14
2016 15
2017 17
2018 21
2019 19
2020 16
2021 27
2022 20
2023 12
2024 9
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Results by year

Filters applied: . Clear all
Page 1
Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma.
Puram SV, Mints M, Pal A, Qi Z, Reeb A, Gelev K, Barrett TF, Gerndt S, Liu P, Parikh AS, Ramadan S, Law T, Mroz EA, Rocco JW, Adkins D, Thorstad WL, Gay HA, Ding L, Paniello RC, Pipkorn P, Jackson RS, Wang X, Mazul A, Chernock R, Zevallos JP, Silva-Fisher J, Tirosh I. Puram SV, et al. Among authors: gay ha. Nat Genet. 2023 Apr;55(4):640-650. doi: 10.1038/s41588-023-01357-3. Epub 2023 Apr 3. Nat Genet. 2023. PMID: 37012457 Free PMC article.
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, Spies NC, Lin T, Li T, Mulder DT, Hanna Y, Cirlan I, Pugh TJ, Mudianto T, Riley R, Zhou L, Jo VY, Stachler MD, Hanna GJ, Kass J, Haddad R, Schoenfeld JD, Gjini E, Lako A, Thorstad W, Gay HA, Daly M, Rodig SJ, Hagemann IS, Kallogjeri D, Piccirillo JF, Chernock RD, Griffith M, Griffith OL, Adkins DR. Uppaluri R, et al. Among authors: gay ha. Clin Cancer Res. 2020 Oct 1;26(19):5140-5152. doi: 10.1158/1078-0432.CCR-20-1695. Epub 2020 Jul 14. Clin Cancer Res. 2020. PMID: 32665297 Free PMC article. Clinical Trial.
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.
Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM. Gay HA, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e353-62. doi: 10.1016/j.ijrobp.2012.01.023. Epub 2012 Apr 6. Int J Radiat Oncol Biol Phys. 2012. PMID: 22483697 Free PMC article.
Reply by Authors.
Andruska N, Fischer-Valuck BW, Waters M, Juarez Diaz E, Agabalogun T, Kim EH, Smith ZL, Brenneman RJ, Gay HA, Andriole GL, Michalski JM, Baumann BC. Andruska N, et al. Among authors: gay ha. J Urol. 2022 Jun;207(6):1235. doi: 10.1097/JU.0000000000002455.02. Epub 2022 Mar 14. J Urol. 2022. PMID: 35282697 No abstract available.
Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Hamstra DA, Bosch W, Gay H, Michalski J. Mariados N, et al. Among authors: gay h. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-977. doi: 10.1016/j.ijrobp.2015.04.030. Epub 2015 Apr 23. Int J Radiat Oncol Biol Phys. 2015. PMID: 26054865 Free article. Clinical Trial.
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, Vigneault E, Winter K, Sandler H. Michalski JM, et al. Among authors: gay h. JAMA Oncol. 2018 Jun 14;4(6):e180039. doi: 10.1001/jamaoncol.2018.0039. Epub 2018 Jun 14. JAMA Oncol. 2018. PMID: 29543933 Free PMC article. Clinical Trial.
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Wisdom AJ, Yeap BY, Michalski JM, Horick NK, Zietman AL, Christodouleas JP, Kamran SC, Parikh RR, Vapiwala N, Mihalcik S, Miyamoto DT, Zeng J, Gay HA, Pisansky TM, Mishra MV, Spratt DE, Mendenhall NP, Soffen EM, Bekelman JE, Efstathiou JA. Wisdom AJ, et al. Among authors: gay ha. Int J Radiat Oncol Biol Phys. 2025 Mar 1;121(3):741-751. doi: 10.1016/j.ijrobp.2024.09.043. Epub 2024 Sep 30. Int J Radiat Oncol Biol Phys. 2025. PMID: 39357788 Clinical Trial.
274 results